Stay updated on Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial page.

Latest updates to the Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial page
- Check5 days agoChange DetectedUpdated the version from v3.0.1 to v3.0.2 and removed the Back to Top element.SummaryDifference0.8%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.8%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference9%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Clinical Trial page.